A. S. Walker

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Scott A. Prentice, Tom Michael Mitchell, Deborah A. Gilliam, 2018, Lancet.

Survival following Staphylococcus aureus bloodstream infection: A prospective multinational cohort study assessing the impact of place of care.

M. Hellmich, F. Ruffin, V. Fowler, 2018, The Journal of infection.

Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998-2016: a study of electronic health records.

S. Hopkins, N. Stoesser, L. Dunn, 2018, The Lancet. Infectious diseases.

Impact of hospital antibiotic use on patient­level risk of death among 36,124,372 acute and medical admissions in England

T. Donker, M. Llewelyn, M. Gill, 2022 .

‘Caveat emptor’: the cautionary tale of endocarditis and the potential pitfalls of clinical coding data—an electronic health records study

A. Walker, T. Peto, D. Crook, 2019, BMC Medicine.

Development and validation of the Baseline Recurrence Risk in Cellulitis (BRRISC) score.

M. Llewelyn, T. Quan, A. S. Walker, 2023, The Journal of infection.